On June 20, 2016, the Ministry of Healthcare of the Russian Federation issued Marketing Authorization No. ЛП-003 689 for innovative cardioplegic drug - Normacor®
Welcome to our web site!
Please bear in mind that this project is intended for cardiology centers physicians and specialists only.